Public
All

ST PHARM's Public Release

Media FocusST PHARM Present Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022Aug 4, 2022
Media FocusST PHARM Scores FDA's cGMP Certification (NAI) for Oligo PlantAug 2, 2022
Media FocusST PHARM's Banwol Campus 'Oligo Manufacturing Plants' cGMP Certified by USA FDAAug 1, 2022
Media FocusST PHARM's Cutting-edge Technology to Reduce the Cost of Promising DrugJul 28, 2022
ST PHARM NewsST PHARM 'STP1002' Preclinical Result EJC PublishedJul 19, 2022
ST PHARM NewsST PHARM Acquired EcoVadis Silver Grade CertificationJul 11, 2022
ST PHARM NewsST PHARM Announces HIV-1 / AIDS Treatment Drug 'STP0404' Phase 1 Clinical Trial Results 'Positive and Safe'Jul 6, 2022
Media FocusST PHARM to Supply Lipids to Biotech in North AmericaMay 4, 2022
ST PHARM NewsST PHARM, Awarded 2022 Asia-Pacific Oligonucleotide CDMO Campany by Frost & SullivanMay 2, 2022
ST PHARM NewsST PHARM, Participated in TIDES USA 2022 Conference As a Gold sponsorMay 2, 2022
Media FocusKorean drugmakers team up with CEPI to become global vaccine suppliersDec 27, 2021
Media FocusST Pharm receives presidential award for improving labor-management relationsDec 1, 2021
Media FocusKorea-based ST Pharm takes leap towards world's largest oligonucleotide CDMONov 30, 2021
1of2
HOMEPublicPR (Public Relations)News roomAll
© 2022 ST Pharm. All rights reserved.